Concepedia

Mark S. Watkins

MS

2

Publications

43

Citations

2

H-Index

2019

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Mark S. Watkins is an author at GlaxoSmithKline (United States) specializing in allergy, immunosuppression, and complement system.

Top concepts

Publications per year

2019–2020

2

Publications

2

Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor

David F. Adams, Mark S. Watkins, Luc Durette et al. · Toxicologic Pathology · 2019 · 27 citations

Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates

Susan Laffan, Andrew S. Thomson, Shing Mai et al. · PLoS ONE · 2020 · 16 citations · Full text

, , +19

Rows per page

1–2 of 2